Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andrew Stone

Showing results (41-50 of 58) with videos related to

Pageof 6
Sort By:
British Journal of Cancer|February 21, 2019
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancerMichael J G Milevskiy, Udai Gujral, Carolina Del Lama Marques, et al.
Blood Advances|March 24, 2024
SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrowIsabelle Allaeys, Guillaume Lemaire, Mickaël Leclercq, et al.
Plos One|July 19, 2012
Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancerAndrew Stone, Fatima Valdés-Mora, Julia M W Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126Jeffrey L Evelhoch, Patricia M LoRusso, Zhanquan He, et al.
Genome Announcements|July 27, 2013
Genome assembly of citrus leprosis virus nuclear type reveals a close association with orchid fleck virusAvijit Roy, Andrew Stone, Gabriel Otero-Colina, et al.
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
The American Journal of Surgical Pathology|April 14, 2026
Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative DisordersPhilip Bulterys, Christine W Zhou, Shunyou Gong, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2026
Multicentre evaluation of teicoplanin prescribing and monitoring in the UK and Ireland: the TUcK-SHOP studyStephen Hughes, Jamie Cheong, Jonathan Snape, et al.
Pageof 6

Showing results (41-50 of 58) with videos related to

Sort By:
Pageof 6
British Journal of Cancer|February 21, 2019
MicroRNA-196a is regulated by ER and is a prognostic biomarker in ER+ breast cancerMichael J G Milevskiy, Udai Gujral, Carolina Del Lama Marques, et al.
Blood Advances|March 24, 2024
SARS-CoV-2 infection modifies the transcriptome of the megakaryocytes in the bone marrowIsabelle Allaeys, Guillaume Lemaire, Mickaël Leclercq, et al.
Plos One|July 19, 2012
Tamoxifen-induced epigenetic silencing of oestrogen-regulated genes in anti-hormone resistant breast cancerAndrew Stone, Fatima Valdés-Mora, Julia M W Gee, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 3, 2004
Magnetic resonance imaging measurements of the response of murine and human tumors to the vascular-targeting agent ZD6126Jeffrey L Evelhoch, Patricia M LoRusso, Zhanquan He, et al.
Genome Announcements|July 27, 2013
Genome assembly of citrus leprosis virus nuclear type reveals a close association with orchid fleck virusAvijit Roy, Andrew Stone, Gabriel Otero-Colina, et al.
Nature Communications|July 15, 2015
DNA methylation of oestrogen-regulated enhancers defines endocrine sensitivity in breast cancerAndrew Stone, Elena Zotenko, Warwick J Locke, et al.
Molecular Cancer Therapeutics|May 9, 2012
Cyclin E2 overexpression is associated with endocrine resistance but not insensitivity to CDK2 inhibition in human breast cancer cellsC Elizabeth Caldon, C Marcelo Sergio, Jian Kang, et al.
Molecular Cancer Therapeutics|July 18, 2013
BCL-2 hypermethylation is a potential biomarker of sensitivity to antimitotic chemotherapy in endocrine-resistant breast cancerAndrew Stone, Mark J Cowley, Fatima Valdes-Mora, et al.
The American Journal of Surgical Pathology|April 14, 2026
Clinicopathologic and Molecular Characteristics of Merkel Cell Polyomavirus Positive T-Cell Lymphoproliferative DisordersPhilip Bulterys, Christine W Zhou, Shunyou Gong, et al.
The Journal of Antimicrobial Chemotherapy|February 19, 2026
Multicentre evaluation of teicoplanin prescribing and monitoring in the UK and Ireland: the TUcK-SHOP studyStephen Hughes, Jamie Cheong, Jonathan Snape, et al.
Pageof 6